Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $182
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice Target
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $164 to $182.
Keybanc analyst Brett Fishbin maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $164 to $182.